However, when combined with anti-PD-L1 ICB therapy, the polyepitope Ubmut-E0771 neoantigen DNA vaccine was able to enhance the antitumor response and suppress E0771 tumor growth for the duration of the experiment (Fig. 3a, b). The gene discussed is CD274; the disease is neoplasm.